Our analysis of drug‐sensitive breast cancer cells indicated that MET inhibited cell proliferation and invasion by increasing the expression of the classical Hippo upstream regulators, KIBRA and FRMD6 (Figure 7A). The gene discussed is FRMD6; the disease is breast carcinoma.